Critics worry the administration’s delays come at a steep cost: Medicare is continuing to pay for millions of unnecessary exams and patients are being subjected to radiation for no medical benefit.
Congress has told the Centers for Disease Control and Prevention not to “advocate or promote gun control.” That directive complicates the public health agency’s efforts to prevent suicide.
The snakebite antivenin CroFab, on the U.S. market since 2000, now faces competition from a drug called Anavip. But both are expensive. “Perverse incentives” keep prices high, says one legal scholar.
Tennessee’s innovative Medicaid program is offering bonuses to mental health providers who help make sure their Medicaid patients get preventive help and treatment for physical ailments too.
An interdisciplinary team in San Francisco uses acupressure, massage, counseling and other methods, as well as medicine, to help kids get relief from chronic pain. But such pediatric centers are rare.
The Trump administration announced plans to allow the importation of prescription drugs from Canada. But the plan is just the first step and is likely to face challenges.
For the first time, doctors have used the gene-editing technique CRISPR to treat a genetic disorder in the U.S. The patient, who has sickle cell disease, spoke with NPR about her treatment.
The amount of meth seized in the U.S. more than doubled from 2017 to 2018. That translates to lots more meth, along with cocaine and other stimulants, on the streets — and likely more deaths.
The medical bill of the month story that Morning Edition brought you last Monday — half a million dollars for kidney dialysis — has been reduced to zero by the company that owns the dialysis center.